Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Infectious Diseases

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Hepatitis a virus genotypes and strains from an endemic area of Europe, Bulgaria 2012–2014

  • Roberto Bruni1Email authorView ORCID ID profile,
  • Stefania Taffon1,
  • Michele Equestre2,
  • Eleonora Cella3,
  • Alessandra Lo Presti3,
  • Angela Costantino1,
  • Paola Chionne1,
  • Elisabetta Madonna1,
  • Elitsa Golkocheva-Markova4,
  • Diljana Bankova4,
  • Massimo Ciccozzi3,
  • Pavel Teoharov4 and
  • Anna Rita Ciccaglione1
BMC Infectious DiseasesBMC series – open, inclusive and trusted201717:497

https://doi.org/10.1186/s12879-017-2596-1

Received: 3 February 2017

Accepted: 6 July 2017

Published: 14 July 2017

Abstract

Background

Hepatitis A virus (HAV) infection is endemic in Eastern European and Balkan region countries. In 2012, Bulgaria showed the highest rate (67.13 cases per 100,000) in Europe. Nevertheless, HAV genotypes and strains circulating in this country have never been described. The present study reports the molecular characterization of HAV from 105 patients from Bulgaria.

Methods

Anti-HAV IgM positive serum samples collected in 2012–2014 from different towns and villages in Bulgaria were analysed by nested RT-PCR, sequencing of the VP1/2A region and phylogenetic analysis; the results were analysed together with patient and geographical data.

Results

Phylogenetic analysis revealed two main sequence groups corresponding to the IA (78/105, 74%) and IB (27/105, 26%) sub-genotypes.

In the IA group, a major and a minor cluster were observed (62 and 16 sequences, respectively). Most sequences from the major cluster (44/62, 71%) belonged to either of two strains, termed "strain 1" and "strain 2", differing only for a single specific nucleotide; the remaining sequences (18/62, 29%) showed few (1 to 4) nucleotide variations respect to strain 1 and 2. Strain 2 is identical to the strain previously responsible for an outbreak in the Czech Republic in 2008 and a large multi-country European outbreak caused by contaminated mixed frozen berries in 2013.

Most sequences of the IA minor cluster and the IB group were detected in large/medium centers (LMCs). Overall, sequences from the IA major cluster were more frequent in small centers (SCs), but strain 1 and strain 2 showed an opposite relative frequency in SCs and LMCs (strain 1 more frequent in SCs, strain 2 in LMCs).

Conclusions

Genotype IA predominated in Bulgaria in 2012–2014 and phylogenetic analysis identified a major cluster of highly related or identical IA sequences, representing 59% of the analysed cases; these isolates were mostly detected in SCs, in which HAV shows higher endemicity than in LMCs. The distribution of viral sequences suggests the existence of some differences between the transmission routes in SCs and LMCs.

Molecular characterization of an increased number of isolates from Bulgaria, regularly collected over time, will be useful to explore specific transmission routes and plan appropriate preventing measures.

Keywords

Hepatitis a virusHAVHepatitisPhylogenetic analysisSequencingBulgaria

Background

Hepatitis A virus (HAV) is one of the major causes of acute hepatitis throughout the world and causes substantial morbidity in both developed and developing countries [1, 2]. On the basis of genome sequence divergence, all viruses infecting humans have been classified in three genotypes (I, II, III), further divided into two sub-genotypes (A and B). Genotypes and subtypes tend to show different geographic distribution [3].

HAV is mainly transmitted by the faecal-oral route. HAV can survive for long in water and numerous waterborne epidemics have been observed following consumption of contaminated drinking water [4], food produce [5, 6], or shellfish [7].

The infection is usually asymptomatic or mild in children under five years, while in adults more frequently occurs with symptoms and jaundice. Clearance of infection confers lifelong immunity. In high endemicity countries, HAV infection is acquired in early childhood and most adult population is positive for anti-HAV IgG and protected from re-infection. In contrast, in low endemicity countries most adult population is susceptible: as a result, infections are more likely to occur in adults, in which are frequently symptomatic [8].

In Europe, the epidemiology of the HAV infection is characterized by countries with variable endemicity. In 2012, the European Centre for Disease Prevention and Control (ECDC) reported a mean rate of infection in Europe of 2.6 cases per 100,000 inhabitants (13,156 total confirmed cases). The majority of them were from an endemic area which included Eastern European and Balkan region countries [9]. Among them, Bulgaria is a country with intermediate hepatitis A endemicity, with annual incidence between 25 and 94 cases per 100,000 population (data since 2000). In 2011 and 2012 the cases increased to 75.88/100,000 (5588 cases) and 67.13/100,000 (4919 cases), respectively, then decreased to 25.05/100,000 in 2013 (1825 cases) [10].

In 2011–2013, the most affected population group was children aged 5–9 years, followed by the 10–14 years and 1–4 years age groups, which are the main risk groups for the disease in Bulgaria in general. During this time, 28 outbreaks of hepatitis A were detected in different Bulgarian districts, affecting dominantly minority Roma neighbourhoods [9, 10]. The prevalence of anti-HAV antibodies in general population in Bulgaria is poorly known. The only available data were from a small study carried out in Plovdiv, the second largest town in Bulgaria, in which two quarters with very different hygienic and sanitary conditions were sampled [11]. The mean seroprevalence was 68.3%, but it reached 90.2% in the quarter with poor hygienic and sanitary conditions and 44.8% in the other with normal conditions [11]. Vaccination in Bulgaria is recommended for people at risk [12]; however, targeted immunization campaigns are launched in response to outbreaks, such as in 2006 [13].

Molecular analysis of HAV isolates has proved to be crucial for understanding the demographic, social and environmental factors that have given rise to the current epidemiological patterns in Europe. Several studies described circulation of different HAV genotypes from both autochthonous and travel-related cases [1421]. Nevertheless, HAV strains from Bulgaria and other European endemic countries have never been described. This gap delays the comprehension of the local transmission routes and the implementation of control measures in areas that urgently need them.

In the present study, serum samples from 105 patients with acute hepatitis A, collected in different towns and villages in Bulgaria during 2012–2014, were analysed by nested RT-PCR and sequencing to characterize HAV isolates. Phylogenetic analysis of sequences was performed to describe, for the first time, HAV genotypes and strains circulating in Bulgaria.

Methods

Patients

The Department of Virology of the National Center of Infectious and Parasitic Diseases in Bulgaria receives serum samples from patients with acute hepatitis (according to the clinical definition by World Health Organization (WHO) [22]) from all over the country for laboratory testing. One hundred and five anti-HAV IgM positive sera from cases occurred during 2012–2014 in several towns/villages, mostly in West Bulgaria, had been randomly stored and were available for the present study. Anti-HAV IgM antibodies had been detected by the HAV IgM ELISA kit (Dia.Pro, Diagnostic BioProbes s.r.l., Italy). All the 105 cases were classified as confirmed HAV infections on the basis of specific IgM antibody detection according to the recommended case definition by WHO [22]. Among them, 91.4% were Bulgarian, 51.4% were males, the mean age of the patients was 21 years, ranging from 2 to 78. HAV characterization by nested RT-PCR and sequencing was carried out in Italy at the National Reference Laboratory for Hepatitis Viruses - Istituto Superiore di Sanità (NRL-ISS) (see next paragraph). Informed consent for participation in the study had been obtained before patient discharge. The study was approved by the Ethics Committee at the National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria.

Nested RT-PCR and sequencing

Viral RNA was extracted from 140 μL serum by using the QIAmp viral RNA extraction kit (Qiagen, Hilden, Germany). One sixth extracted RNA (10 μL) was reverse transcribed by the SuperScript III First-Strand Synthesis System for RT-PCR (Invitrogen) with random hexamers. Nested PCR was carried out as previously reported [14, 15]. To control for possible PCR contamination, negative control sera were included in each run: they were extracted, reverse transcribed and amplified by nested PCR along with the sera under study. Double strand sequencing of purified PCR products obtained from human sera was carried out by using the GenomeLab Dye Terminator Cycle Sequencing (DTCS) Quick Start Kit and an automated DNA sequencer (both kit and instrument by Beckman Coulter, Inc., Fullerton, CA). The sequencing reaction was carried out according to the manufacturer instructions. In brief, 20–40 ng purified DNA was used as template with 3.2 pmoles of primer and DTCS Quick Start Master Mix, in a 20 μL final volume. The reaction was subjected to 30 cycles of: 96 °C, 20 s; 50 °C, 20 s; 60 °C, 4 min.

The sequenced region encompassed the VP1/2A region of HAV genome (460 nt, positions 2915 to 3374 in the HM-175 reference sequence Acc.No. NC_001489).

Sequence analysis

Genotype was assigned by phylogenetic analysis of a dataset containing 105 HAV sequences from Bulgaria [GenBank:KX858970 to KX859074] plus 13 HAV reference sequences representative of genotypes and sub-genotypes (sub-genotype IA [GenBank:EF406357; KC182590; X75215; X83302], sub-genotype IB [GenBank:AF314208; M20273; NC001489; AF268396], sub-genotype IIA [GenBank:AY644676], sub-genotype IIB [GenBank:AY644670], sub-genotype IIIA [GenBank:AJ299464; KF706410], sub-genotype IIIB [GenBank:AB258387]).

Phylogenetic relationships were analysed by constructing a Neighbor-Joining phylogenetic tree by MEGA 6.0 [23]. The best substitution model (T92 + G) was selected by analysis of sequences with the Models tool in MEGA. Tree reliability was assessed by setting bootstrap replicates to 1000. Bootstrap values >70 were considered significant.

Mean intra-group identity level was calculated from the output identity matrix obtained by the Sequence Identity Matrix function in BioEdit 7.2.5 [24].

Results

Distribution of patients according to age and size of urban centers

According to official data of 2011 census, urban centers were classified in large to medium centers (LMCs) (>30,000 inhabitants, range 44,000–1,203,000) and small centers (SCs) (<30,000 inhabitants, range 132–27,000). One hundred and five patients with acute HAV infection were evaluated in the study. Among them, 46 (43.8%) were from large to medium centers (LMCs) and 50 47.6%) from small centers (SCs). Nine subjects (8.6%), of unknown nationality, were from a refugee camp in Bulgaria. The age was known for 102 patients and their classification into three age categories (Children: 0–12; Teens: >12 to 19; Adults: >19) indicated that 48 (47.1%) were children, 13 (12.7%) teens and 41 (40.2%) adults.

Distribution of hepatitis A cases according to the size of urban centers revealed an opposite age distribution pattern in LMCs and SCs (Fig. 1). The percentages of children and adults were 33.3% and 53.3%, respectively, in patients from LMCs, while they were 54.0% and 32.0% in patients from SCs (p < 0.05, Fisher’s exact test). The percentage of teens was similar in the two groups.
Fig. 1

Distribution of molecularly characterized hepatitis A cases according to age categories and size of urban centers. The distribution in three age groups (Children: 0–12 years; Teens: >12 to 19 years; Adults: > 19 years) according to the size of urban centers (Large and medium centers: >30,000 inhabitants, range 44,000–1,203,000; Small centers: <30,000 inhabitants, range 132–27,000) is reported

Genotyping of HAV strains

Phylogenetic analysis of the 105 HAV isolates from Bulgaria and reference sequences with known genotype revealed two main groups corresponding to the IA (n = 78) and IB (n = 27) sub-genotypes (Fig. 2). No genotype II or III isolates were observed.
Fig. 2

Neighbour-Joining phylogenetic tree (Substitution model: T92 + G) of the 105 HAV isolates from Bulgaria. For each sequence, the town/village (Bis: Bistritsa; Bot: Botevgrad; DoB: Dolna Banja; Dog: Doganovo; ElP: Elin Pelin; Etr: Etropole; Gab: Gabrovo; Iht: Ihtiman; Kju: Kjustendil; Kob: Kostinbrod; Kon: Kostenets; MaR: Manaselska Reka; NoH: Novi Han; Nov: Novachene; Per: Pernik; Pir: Pirdop; Pra: Pravetz; Sam: Samokov; Shu: Shumen; Skr: Skravena; Sof: Sofia; Svo: Svoge; Var: Varna; Ver: Verinsko; refg: refugee, village information not available), the isolation year (2012, 2013, 2014) and the age group of the patient (A: Adult; t: teenager; c: child; n.k.: not known) are reported after the sequence ID. Reference strains with known genotype (IA, IB, IIA, IIB, IIIA, IIIB) were included in the analysis and are reported (in bold) by Accession number followed by the sub-genotype they belong to. Significant bootstrap values are reported. The asterisk shows a small outbreak of 9 cases from Ihtiman occurred between 25 June and 8 August 2012 and involving 6 children and 3 teenagers: the complete nucleotide identity of the isolates confirms a local small outbreak caused by the same strain

In the IA group two main statistically supported clusters can be observed (Fig. 2, labelled as “MAJOR cluster” and “minor cluster”). The major cluster included sequences (n = 62, 79.5% of IA isolates) showing a very high intra-cluster identity level (mean value 99.6%¸ range 98%–100%).

The minor cluster contained IA sequences (n = 16, 20.5% of IA isolates) characterized by a lower intra-cluster identity level (mean value 98.1%¸ range 93.7%–100%).

In the IB group, the 27 sequences showed a high identity level (mean value 99.1%¸ range 98%–100%). Among the IB isolates from 9 patients living in a refugee camp in Bulgaria, 2 small clusters (each containing 3 isolates) of identical sequences were observed. Although the sequences from refugees showed a tendency to cluster separately from the other IB isolates, bootstrap values were not significant: sequences from refugees showed high identity (1 to 4 nt differences) with several sequences from Bulgarian patients circulating in the same (2014) and in the previous years (2012 and 2013) suggesting that refugees got infected with local strains.

To include in the phylogenetic analysis also the proposed sub-genotype IC [17], a separate analysis limited to a shorter region (261 nt) had to be carried out; in fact the available reference IC sequences only partially overlapped with the region sequenced in the present study. IC isolates formed a separate cluster, intermediate between IA and IB; however, none of the Bulgarian isolates grouped with them (data not shown).

Nucleotide variations in strains from the IA major cluster

To better compare HAV isolates from the IA major cluster, one of them, the ISS49_DoB, was chosen as reference sequence. Based on this, the 62 isolates from the major cluster were classified into three groups as follows (see also Fig. 2): (1) “strain 1” group, including 22 (35.5%) sequences (21 sequences showing 100% identity with ISS49_DoB plus the reference sequence itself); (2) “strain 2” group, including 22 (35.5%) sequences presenting only 1 nucleotide (nt) difference with ISS49_DoB, with all isolates showing the same nt difference in the same position (nt 403, C  T, numeration of [GenBank:KF182323]); strain 2 is identical to a strain (reference sequence [GenBank:KF182323] in Fig. 2) previously reported to be responsible for both an outbreak in the Czech Republic in 2008 and a large European outbreak caused by mixed frozen berries in 2013 [15]; (3) “strains related to strain 1 and 2” group, including 18 (29%) sequences showing 1 to 4 nucleotide differences versus ISS49_DoB (individual nucleotide variations were scattered in different positions) (Fig. 2, see the box). Overall, strain 1 and strain 2 represent 44/62 (71%) isolates of the major cluster; 12 distinct variants could be recognised in the remaining 18/62 (29%) isolates of this cluster.

By linking epidemiological and sequence data, a small outbreak of 9 cases could be clearly identified in the major cluster. All cases were from Ihtiman village and occurred between 25 June and 8 August 2012, involving 6 children and 3 teenagers: the complete identity of the isolates confirms a local small outbreak caused by the strain 1 during a period of two months (Fig. 2, MAJOR cluster, labelled by the asterisk).

Distribution of HAV genotypes and strains in urban centers of different size

Distribution of HAV genotypes according to the size of the town/village of patients showed that the percentages of isolates belonging to IA major cluster, IA minor cluster and IB group were 42.2%, 31.1% and 26.7%, respectively, in patients from LMCs and 86.0%, 2.0% and 12.0% in patients from SCs (Fig. 3a). Most isolates from the IA major cluster (43/62, 69.4%) were identified in patients from SCs. In contrast, all but one strains from the IA minor cluster were observed in patients from LMCs, suggesting that different transmission routes, linked to urbanization, operate in these cases. Among the IB sub-genotype, isolates were identified in both LMCs and SCs, however the frequency was higher in patients from LMCs (26.7% in LMCs vs 12% in SCs) (Fig. 3a). Analysis of the 62 isolates from the IA major cluster revealed a different frequency of strain 1 and strain 2 in LMCs and SCs (Fig. 3b): strain 1 largely prevailed in SCs (5.3% in LMCs vs. 48.8% in SCs), strain 2 prevailed in LMCs (63.1% in LMCs vs. 23.3% in SCs) (p < 0.001, Fisher’s exact test); in contrast, the strains related to strain 1 and 2 showed similar frequency (31.6% vs. 27.9%).
Fig. 3

Distribution of strains according to the size of urban centers. a Distribution of the strains from the IA Major cluster, IA minor cluster and IB cluster according to the size of urban centers (see the legend of Fig. 1). The percent values are shown. b Detail of the number of cases and relative frequency of the strains from the IA Major cluster (strain 1, strain 2 and strains related to strain 1 and 2) in LMCs and SCs

Analysis of the geographical localization of the strains in Bulgaria map showed that strain 1 was preferentially detected in a restricted area south-east of Sofia, strain 2 and strains related to strain 1 and 2 showed a more scattered distribution, whereas most strains from the IA minor cluster and IB strains were observed in large towns such as Sofia, Pernik, Shumen, Gabrovo and Varna (Fig. 4).
Fig. 4

Geographical localization of the characterized strains in Bulgarian towns/villages. The name of centers >30,000 inhabitants is reported in larger font size than the name of centers <30,000 inhabitants

Discussion

The ECDC surveillance report of food- and waterborne diseases, published in 2014, defined Bulgaria as the European country that reported the highest number of hepatitis A cases in 2011 (5587 cases) and 2012 (4919 cases). Investigation of a large outbreak in Bulgaria, occurred in 2012 in the Iskra village in the Plovdiv region, indicated that unregulated and/or frequently failing water supply and sewage system are associated with virus spread in this area [9]. Despite the level of endemicity, molecular epidemiology of HAV in Bulgaria has never been described. Thus, the studied samples represent an extremely rare resource, if not unique, to obtain information on HAV strains that have circulated and might still be circulating in an Eastern Europe country. The results of the present study represent the first analysis of the HAV genotypes and strains circulating in Bulgaria.

Analysis of the age distribution showed that patients were younger in SCs than in LMCs, suggesting different endemicity among these areas. In SCs, high HAV endemicity results in a large proportion of adults protected by antibodies developed in childhood and, thus, HAV circulation mainly in children. High endemicity in SCs is likely related to poor hygienic conditions and health education of the population, as suggested by a study investigating an outbreak occurred in 2012 in a SC (Iskra village) [25].

Molecular characterization of HAV from 105 acute hepatitis A cases, collected between 2012 and 2014, indicated that both IA and IB sub-genotypes circulate in Bulgaria; however, about 74% of the isolates were assigned to sub-genotype IA that, thus, seems to be dominant.

Interestingly, IA strains grouped in two distinct phylogenetic clusters. The major cluster, that included 79.5% of the IA cases and 59% of the total cases, contained highly related viruses. Sequence analysis indicated that isolates were either identical (at least over the analysed genomic region), as observed in strain 1 or strain 2 groups, or showed very few (1 to 4) nucleotide variations. Strain 1 and strain 2 groups differed each other for a single specific nucleotide, that was T in strain 1 and C in strain 2. The very low level of variability observed in the IA major cluster might be the result of a common origin of the two main strains and of their spread in the local population, with random generation of new variants, highly related to the main strains, in the course of endemic and epidemic circulation.

The distribution of strains according to urban size (Fig. 3b) and the geographical localization of the involved urban centers (Fig. 4) indicate that strain 1 preferentially circulated in small urban centers and villages south-east of Sofia, where transmission was likely maintained by poor water supply and lack of infrastructures. Although the relative frequency of strain 2 was higher in LMCs than in SCs (Fig. 3b), strain 2 showed wider geographical distribution than strain 1 (Fig. 4) and it was detected both in large urban centers, such as Sofia, Pernik and Shumen, and in small villages.

A completely different pattern of circulation was observed for isolates from the IA minor cluster and from the IB cluster. In fact, all but one patients infected with strains from the IA minor cluster and two thirds of cases infected with IB strains were from LMCs (Fig. 3a), suggesting that different transmission routes, linked to urbanization, might operate in these cases (e.g. consumption of shellfish or other food, contaminated in the same or other countries).

Assuming the distribution of HAV genotypes and strains reported in the present study roughly represents isolates circulating in Bulgaria in 2012–2014, it is conceivable that the IA strains from the IA major cluster, accounting for 59% of sequenced cases, were responsible for the epidemic peak observed in Bulgaria in 2011 and 2012 and, most likely, for the multiple outbreaks detected in different Bulgarian districts during those years [9, 10].

Conclusions

This is the first study describing the HAV genotypes and strains circulating in Bulgaria, one of the European countries with intermediate endemicity. Genotype IA predominates, with several highly related strains. Further studies need to be carried out to increase the number of molecularly characterised isolates from Bulgaria and from other countries of Eastern Europe that, by a phylogenetic approach, can be useful to investigate the factors underlying the spread of HAV infections and to implement appropriate preventing measures, at both national and European level.

Abbreviations

HAV: 

Hepatitis A Virus

LMCs: 

Large/Medium Centers

RT-PCR: 

Reverse Transcription and Polymerase Chain Reaction

SCs: 

Small Centers

Declarations

Acknowledgements

The authors are very grateful to the many physicians and employees of Bulgarian health system for their silent but valuable work that allowed the present study.

Authors’ contribution

ARC, RB, PT and MC conceived the study and participated in its design and coordination; ST, ME, AC, PC and EM conceived the experimental design of PCR and sequencing, carried out the experiments and elaborated raw data; ST, EC and ALP performed editing, alignment and quality control of sequences; RB and ARC performed phylogenetic and statistical analysis, prepared visualization of data and drafted the manuscript; RB, EG, DB, PT and ARC critically reviewed and edited the draft. All authors critically revised the intellectual content of the paper and approved the final manuscript.

Funding

The study received no specific funding.

Availability of data and materials

Sequence data that support the findings of this study have been deposited in GenBank (https://www.ncbi.nlm.nih.gov/genbank/) with the following accession numbers: [GenBank:KX858970 to KX859074].

Ethics approval and consent to participate

Informed consent for characterization of virus in samples was obtained from each patient before discharge. The study was approved by the Ethics Committee at the National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria.

Consent for publication

Not applicable (no individual person’s data).

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
National Reference Laboratory for HAV, Viral Hepatitis Unit, Department of Infectious Diseases, Istituto Superiore di Sanità
(2)
Department of Neurosciences, Istituto Superiore di Sanità
(3)
Epidemiology Unit, Department of Infectious Diseases, Istituto Superiore di Sanità
(4)
Department of Virology, National Center of Infectious and Parasitic Diseases

References

  1. Franco E, Meleleo C, Serino L, Sorbara D, Zaratti L. Hepatitis A: Epidemiology and prevention in developing countries. World J Hepatol. 2012;4:68–73.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Koff RS, Hepatitis A. Lancet. 1998;351:1643–9.View ArticlePubMedGoogle Scholar
  3. Vaughan G, Goncalves Rossi LM, Forbi JC, de Paula VS, Purdy MA, Xia G, Khudyakov YE. Hepatitis a virus: host interactions, molecular epidemiology and evolution. Infect Genet Evol. 2014;21:227–43. doi:10.1016/j.meegid.2013.10.023. ReviewView ArticlePubMedGoogle Scholar
  4. Bosch A, Guix S, Sano D, Pintò RM. New tools for the study and surveillance of viral pathogens in water. Curr Opin Biotechnol. 2008;19:295–301.View ArticlePubMedGoogle Scholar
  5. Dentinger CM, Bower WA, Nainan OV, Cotter SM, Myers G, Dubusky LM, Fowler S, Salehi ED, Bell BP. An outbreak of hepatitis a associated with green onions. J Infect Dis. 2001;183:1273–6.View ArticlePubMedGoogle Scholar
  6. Fiore AE. Hepatitis a transmitted by food. Clin Infec Dis. 2004;38:705–15.View ArticleGoogle Scholar
  7. Legeay O, Caudrelier Y, Cordevant C, Rigottier-Gois L, Lange M. Simplified procedure for detection of enteric pathogenic viruses in shellfish by RT-PCR. J Virol Methods. 2000;90:1–14.View ArticlePubMedGoogle Scholar
  8. Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010; 28:6653–6657. doi:10.1016/j.vaccine.2010.08.037.
  9. European Centre for Disease Prevention and Control. Annual epidemiological report 2014 – food- and waterborne diseases and zoonoses. Stockholm: ECDC; 2014. Available from: http://ecdc.europa.eu/en/publications/Publications/food-waterborne-diseases-annual-epidemiological-report-2014.pdf . Accessed 10 July 2017.
  10. European Food Safety Authority, 2014. Tracing of food items in connection to the multinational hepatitis a virus outbreak in Europe. EFSA journal. 2014;12(9):3821, 186 pp. doi:10.2903/j.efsa.2014.3821. Available from: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2014.3821/epdf. Accessed 10 July 2017.
  11. Vatev NT, Atanasova MV, Stoilova YD, Chervenyakova TP, Troyancheva MG. Seroprevalence of hepatitis a viral infection in Plovdiv, Bulgaria. Folia Med (Plovdiv). 2009;51(1):70–3.Google Scholar
  12. Haverkate M, D’Ancona F, Giambi C, Johansen K, Lopalco PL, Cozza V, Appelgren E. on behalf of the VENICE project gatekeepers and contact points. Mandatory and recommended vaccination in the EU, Iceland and Norway: results of the VENICE 2010 survey on the ways of implementing national vaccination programmes. Euro Surveill. 2012;17(22):–20183.Google Scholar
  13. Kojouharova M; Editorial team. Current outbreak of hepatitis A in Bulgaria 2006. Euro Surveill. 2006; 11(10):E061005.1.Google Scholar
  14. Petrignani M, Verhoef L, Vennema H, van Hunen R, Baas D, van Steenbergen JE, Koopmans MP. Underdiagnosis of foodborne hepatitis a, The Netherlands, 2008-2010. Emerg Infect Dis. 2014;20(4):596–602. doi:10.3201/eid2004.130753.View ArticlePubMedPubMed CentralGoogle Scholar
  15. Bruni R, Taffon S, Equestre M, Chionne P, Madonna E, Rizzo C, Tosti ME, Alfonsi V, Ricotta L, De Medici D, Di Pasquale S, Scavia G, Pavoni E, Losio MN, Romanò L, Zanetti AR, Morea A, Pacenti M, Palù G, Capobianchi MR, Chironna M, Pompa MG, Ciccaglione AR; Italian National Task Force on Hepatitis A. Key Role of Sequencing to Trace Hepatitis A Viruses Circulating in Italy During a Large Multi-Country European Foodborne Outbreak in 2013 PLoS One 2016;11(2):e0149642. doi:10.1371/journal.pone.0149642.
  16. Pérez-Sautu U, Costafreda MI, Lite J, Sala R, Barrabeig I, Bosch A, Pintó RM. Molecular epidemiology of hepatitis a virus infections in Catalonia, Spain, 2005-2009: circulation of newly emerging strainsJ Clin Virol. 2011;52(2):98–102. doi:10.1016/j.jcv.2011.06.011. Epub 2011 Jul 27
  17. MacDonald E, Steens A, Stene-Johansen K, Gillesberg Lassen S, Midgley S, Lawrence J, Crofts J, Ngui SL, Balogun K, Frank C, Faber M, Gertler M, Verhoef L, Koopmans M, Sane J, van Pelt W, Sundqvist L, Vold L. Increase in hepatitis A in tourists from Denmark, England, Germany, the Netherlands, Norway and Sweden returning from Egypt, November 2012 to March 2013. Euro Surveill. 2013; 18(17):20468. No abstract available. Erratum in: Euro Surveill. 2013;18(18). pii: 20473.Google Scholar
  18. Desbois D, Couturier E, Mackiewicz V, Graube A, Letort MJ, Dussaix E, Roque-Afonso AM. Epidemiology and genetic characterization of hepatitis a virus genotype IIA. J Clin Microbiol. 2010;48(9):3306–15. doi:10.1128/JCM.00667-10. Epub 2010 Jun 30View ArticlePubMedPubMed CentralGoogle Scholar
  19. Ngui SL, Granerod J, Jewes LA, Crowcroft NS. Teo CG; 2002 hepatitis a outbreaks investigation network. Outbreaks of hepatitis a in England and Wales associated with two co-circulating hepatitis a virus strains. J Med Virol. 2008;80(7):1181–8. doi:10.1002/jmv.21207.View ArticlePubMedGoogle Scholar
  20. Guzman-Herrador BR, Panning M, Stene-Johansen K, Borgen K, Einöder-Moreno M, Huzly D, Jensvoll L, Lange H, Maassen S, Myking S, Myrmel M, Neumann-Haefelin C, Nygård K, Wenzel JJ, Øye AK, Vold L. Importance of molecular typing in confirmation of the source of a national hepatitis a virus outbreak in Norway and the detection of a related cluster in Germany. Arch Virol. 2015;160(11):2823–6. doi:10.1007/s00705-015-2531-y. Epub 2015 Aug 7View ArticlePubMedGoogle Scholar
  21. Faber MS, Stark K, Behnke SC, Schreier E, Frank C. Epidemiology of hepatitis a virus infections, Germany, 2007-2008. Emerg Infect Dis. 2009;15(11):1760–8. doi:10.3201/eid1511.090214.View ArticlePubMedPubMed CentralGoogle Scholar
  22. WHO–recommended standards for surveillance of selected vaccine-preventable diseases, 2003; revised: July 2008. Available at: http://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/passive/hepatitis_standards/en/. Accessed 10 July 2017.
  23. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol. 2013;30:2725–9.View ArticlePubMedPubMed CentralGoogle Scholar
  24. Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for windows 95/98/NT. Nucl Acids Symp Ser. 1999;41:95–8.Google Scholar
  25. Vatev N, Petrov A, Troyancheva M, Stoycheva M, Georgieva V. Clinical, epidemiological and laboratory characteristics of hepatitis a outbreak in the village of Iskra (Plovdiv region - Bulgaria), January - march 2012. International Journal of Pharmaceutical Science Invention. 2013;2(1):8–11.Google Scholar

Copyright

© The Author(s). 2017

Advertisement